A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have Obesity
Clinical trial NCT06662383 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06662383
- Sponsor
- Eli Lilly and Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-01
- Primary completion
- 2026-11-01
- Enrollment
- 800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.